泰格医药(03347.HK)：前三季度净利润10.20亿元 同比增加25.45%

Core Points - The company, Tigermed (03347.HK), reported a revenue of 5.026 billion RMB for the first three quarters of 2025, representing a year-on-year decrease of 0.82% [1] - The net profit attributable to shareholders increased by 25.45% year-on-year, amounting to 1.020 billion RMB [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 326 million RMB, showing a significant year-on-year decrease of 63.46% [1] - The basic earnings per share stood at 1.19 RMB [1]